IART Integra LifeSciences Holdings Corporation
Healthcare$15.17+0.00%OpenMarket Cap: $1.18B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.11
P/S
0.71
EV/EBITDA
-10.88
DCF Value
$36.84
FCF Yield
-0.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.2%
Operating Margin
7.5%
Net Margin
-30.1%
ROE
-47.6%
ROA
-13.9%
ROIC
3.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $391.9M | 57.2% | $40.1M | $-4.6M | $— | — |
| Q4 null | $434.9M | 49.5% | $556.2M | $-1.7M | $— | — |
| FY null | $1.64B | 51.7% | $68.3M | $-516.5M | $— | — |
| Q3 null | $402.1M | 56.2% | $40.3M | $-5.4M | $— | — |
| Q2 null | $415.6M | 50.4% | $-512.7M | $-484.1M | $— | — |
| Q1 null | $382.7M | 50.8% | $-15.5M | $-25.3M | $— | — |
| Q4 null | $442.6M | 56.3% | $35.6M | $19.4M | $— | — |
| FY null | $1.61B | 54.8% | $28.4M | $-6.9M | $— | — |
| Q3 null | $380.8M | 52.6% | $-8.2M | $-10.7M | $— | — |
| Q2 null | $418.2M | 54.0% | $-3.0M | $-12.4M | $— | — |
| Q1 null | $368.9M | 56.1% | $4.0M | $-3.3M | $— | — |
| Q4 2023 | $397.0M | 57.0% | $36.0M | $19.8M | $0.25 | — |